Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin A Hutchison

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 25, 2007
Differences in solute removal by two high-flux membranes of nominally similar synthetic polymersRosemary Ouseph, Colin A Hutchison, Richard A Ward
Kidney International|April 15, 2011
The biology of immunoglobulin free light chains and kidney injuryKolitha Basnayake, Stephanie J Stringer, Colin A Hutchison, et al.
Current Medical Research and Opinion|December 24, 2010
Modelled cost-effectiveness of high cut-off haemodialysis compared to standard haemodialysis in the management of myeloma kidneyDaniel T Grima, Parisa Airia, Cheryl Attard, et al.
Nephrology (Carlton, Vic.)|June 17, 2014
Extended high cut-off haemodialysis for myeloma cast nephropathy in Auckland, 2008-2012Jasmine Tan, Michael Lam-Po-Tang, Colin A Hutchison, et al.
Critical Care (London, England)|April 25, 2007
Case mix, outcome and activity for patients admitted to intensive care units requiring chronic renal dialysis: a secondary analysis of the ICNARC Case Mix Programme DatabaseColin A Hutchison, Alex V Crowe, Paul E Stevens, et al.
Artificial Organs|January 10, 2009
Serum free-light chain removal by high cutoff hemodialysis: optimizing removal and supportive careColin A Hutchison, Stephen Harding, Graham Mead, et al.
Trials|September 30, 2008
European trial of free light chain removal by extended haemodialysis in cast nephropathy (EuLITE): a randomised control trialColin A Hutchison, Mark Cook, Nils Heyne, et al.
Expert Opinion on Therapeutic Targets|May 16, 2008
Quantitative assessment of serum and urinary polyclonal free light chains in patients with type II diabetes: an early marker of diabetic kidney disease?Colin A Hutchison, Paul Cockwell, Steven Harding, et al.
Nephron|February 17, 2021
Expanded Hemodialysis and Its Effects on Hospitalizations and Medication Usage: A Cohort StudyRafael M Sanabria, Colin A Hutchison, Jasmin I Vesga, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 26, 2012
Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysisColin A Hutchison, Nils Heyne, Parisa Airia, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 25, 2007
Differences in solute removal by two high-flux membranes of nominally similar synthetic polymersRosemary Ouseph, Colin A Hutchison, Richard A Ward
Kidney International|April 15, 2011
The biology of immunoglobulin free light chains and kidney injuryKolitha Basnayake, Stephanie J Stringer, Colin A Hutchison, et al.
Current Medical Research and Opinion|December 24, 2010
Modelled cost-effectiveness of high cut-off haemodialysis compared to standard haemodialysis in the management of myeloma kidneyDaniel T Grima, Parisa Airia, Cheryl Attard, et al.
Nephrology (Carlton, Vic.)|June 17, 2014
Extended high cut-off haemodialysis for myeloma cast nephropathy in Auckland, 2008-2012Jasmine Tan, Michael Lam-Po-Tang, Colin A Hutchison, et al.
Critical Care (London, England)|April 25, 2007
Case mix, outcome and activity for patients admitted to intensive care units requiring chronic renal dialysis: a secondary analysis of the ICNARC Case Mix Programme DatabaseColin A Hutchison, Alex V Crowe, Paul E Stevens, et al.
Artificial Organs|January 10, 2009
Serum free-light chain removal by high cutoff hemodialysis: optimizing removal and supportive careColin A Hutchison, Stephen Harding, Graham Mead, et al.
Trials|September 30, 2008
European trial of free light chain removal by extended haemodialysis in cast nephropathy (EuLITE): a randomised control trialColin A Hutchison, Mark Cook, Nils Heyne, et al.
Expert Opinion on Therapeutic Targets|May 16, 2008
Quantitative assessment of serum and urinary polyclonal free light chains in patients with type II diabetes: an early marker of diabetic kidney disease?Colin A Hutchison, Paul Cockwell, Steven Harding, et al.
Nephron|February 17, 2021
Expanded Hemodialysis and Its Effects on Hospitalizations and Medication Usage: A Cohort StudyRafael M Sanabria, Colin A Hutchison, Jasmin I Vesga, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 26, 2012
Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysisColin A Hutchison, Nils Heyne, Parisa Airia, et al.
Pageof 5